Catalent
CTLT
$55.48
Share price
-0.57%
Change (1 day)
31.84%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Market capitalization of Catalent (CTLT)
Market cap: $10.04 Billion
As of April 2024 Catalent has a market cap of $10.04 Billion. This makes Catalent the world's 1562th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Catalent from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $10.04 B | 23.71% |
| 2023 | $8.11 B | 0.2% |
| 2022 | $8.10 B | -64.65% |
| 2021 | $22.91 B | 33.71% |
| 2020 | $17.14 B | 107.95% |
| 2019 | $8.24 B | 81.53% |
| 2018 | $4.54 B | -16.81% |
| 2017 | $5.45 B | 62.28% |
| 2016 | $3.36 B | 7.91% |
| 2015 | $3.11 B | -9.71% |
| 2014 | $3.45 B |
End of Day market cap according to different sources
On Apr 18th, 2024 the market cap of Catalent was reported to be:
$10.09 Billion
$10.09 Billion
$10.07 Billion
$10.09 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $1.60 B | -83.97% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | $6.85 B | -31.73% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | $0.75 B | -92.49% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | $0.79 B | -92.09% | 🇺🇸 USA |